Moreover, approximately 86.48% of the PPIA-high samples showed high expression level of NRF2, whereas 65.62% of clinical NSCLC specimens with low level of PPIA exhibited low NRF2 expression (Table 3, P < 0.001). This evidence concerns the gene PPIA and non-small cell lung carcinoma.